{"protocolSection": {"identificationModule": {"nctId": "NCT03769519", "orgStudyIdInfo": {"id": "Pro00100181"}, "organization": {"fullName": "Duke University", "class": "OTHER"}, "briefTitle": "AdheRence to Inhaled Corticosteroids in Asthma", "officialTitle": "AdheRence to Inhaled Corticosteroids in Asthma", "acronym": "ARICA"}, "statusModule": {"statusVerifiedDate": "2021-11", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2020-02-27", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2020-08-19", "type": "ACTUAL"}, "completionDateStruct": {"date": "2020-08-19", "type": "ACTUAL"}, "studyFirstSubmitDate": "2018-10-16", "studyFirstSubmitQcDate": "2018-12-06", "studyFirstPostDateStruct": {"date": "2018-12-07", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2021-08-11", "resultsFirstSubmitQcDate": "2021-11-18", "resultsFirstPostDateStruct": {"date": "2021-12-17", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2021-11-18", "lastUpdatePostDateStruct": {"date": "2021-12-17", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Duke University", "class": "OTHER"}}, "oversightModule": {"oversightHasDmc": false, "isFdaRegulatedDrug": false, "isFdaRegulatedDevice": false}, "descriptionModule": {"briefSummary": "It is widely recognized that asthma in adult African American patients is a significant health problem, which is partly affected by relatively low inhaled corticosteroid (ICS) adherence rates. The goal of this study is to pilot test an ICS adherence intervention, ARICA, that aims to improve ICS adherence in adult African Americans.", "detailedDescription": "The investigators will evaluate ARICA in Duke primary care clinics to study its feasibility and acceptability using a quasi-experimental pre-post study design. The study will enroll between 32 and 48 adult African Americans with persistent asthma and suboptimal ICS adherence, and their health care providers, to study the use of the intervention and key indicators of the intervention's potential effectiveness."}, "conditionsModule": {"conditions": ["Medication Adherence", "Asthma"], "keywords": ["health disparities", "african american", "adult"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "HEALTH_SERVICES_RESEARCH", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 29, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Control (Group 1)", "type": "NO_INTERVENTION", "description": "This group is considered the control group. This group will have scheduled texts and emails for the monthly surveys after the participant completes the baseline questionnaires."}, {"label": "ARICA Intervention (Group 2)", "type": "EXPERIMENTAL", "description": "This group is considered the intervention group. Participants in this group will receive weekly texts and emails containing asthma facts and myths. They will also complete monthly surveys and participate in asthma education sessions.", "interventionNames": ["Behavioral: ARICA"]}], "interventions": [{"type": "BEHAVIORAL", "name": "ARICA", "description": "Personalized ARICA (AdheRence to Inhaled Corticosteroids in Asthma) intervention package.", "armGroupLabels": ["ARICA Intervention (Group 2)"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Number of Participants Who Reported Experiences With the ARICA Program", "description": "Assessment of participants experiences with and perceptions of the ARICA program, as assessed by in-depth semi-structured qualitative interview.", "timeFrame": "3 months"}], "secondaryOutcomes": [{"measure": "Change in Patient Reported Medication Adherence as Measured by the DOSE-Nonadherence (Voils) Questionnaire", "description": "patients' medication adherence rates based on Voils adherence questionnaire adherence questionnaire. Difference from baseline to follow up. Scored 0-4, higher is more non-adherent", "timeFrame": "3 months"}, {"measure": "Change in Asthma Control as Measured by the Asthma Control Test", "description": "patient reported difference from baseline to follow up. Higher score is better asthma control. Range 5-25.", "timeFrame": "3 months"}, {"measure": "Change in Asthma-Related Quality of Life as Measured by the Marks Asthma-Related Quality of Life Questionnaire", "description": "Patient reported. Difference from baseline to follow up. Range 0-80, higher score means greater impact of asthma on quality of life.", "timeFrame": "3 months"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria\n\n* At least 18 years of age\n* Self-identifying African American\n* Self-reported current asthma\n* Prescribed an inhaled corticosteroid (alone or combination) for \u2265 1 month\n* Presented at a Duke Primary Care clinic visit within the past 3 years or is establishing care at Duke Primary Care\n* Follow up Duke Primary Care visit within the next 6 months\n\nExclusion Criteria:\n\n* Unable or unwilling to provide informed consent", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Isaretta L Riley, MD", "affiliation": "Duke Un.", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Duke Un.", "city": "Durham", "state": "North Carolina", "zip": "27701", "country": "United States", "geoPoint": {"lat": 35.99403, "lon": -78.89862}}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Control (Group 1)", "description": "This group is considered the control group. This group will have scheduled texts and emails for the monthly surveys after the participant completes the baseline questionnaires."}, {"id": "FG001", "title": "ARICA Intervention (Group 2)", "description": "This group is considered the intervention group. Participants in this group will receive weekly texts and emails containing asthma facts and myths. They will also complete monthly surveys and participate in asthma education sessions.\n\nARICA: Personalized ARICA (AdheRence to Inhaled Corticosteroids in Asthma) intervention package."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "14"}, {"groupId": "FG001", "numSubjects": "15"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "14"}, {"groupId": "FG001", "numSubjects": "14"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Control (Group 1)", "description": "This group is considered the control group. This group will have scheduled texts and emails for the monthly surveys after the participant completes the baseline questionnaires."}, {"id": "BG001", "title": "ARICA Intervention (Group 2)", "description": "This group is considered the intervention group. Participants in this group will receive weekly texts and emails containing asthma facts and myths. They will also complete monthly surveys and participate in asthma education sessions.\n\nARICA: Personalized ARICA (AdheRence to Inhaled Corticosteroids in Asthma) intervention package."}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "14"}, {"groupId": "BG001", "value": "15"}, {"groupId": "BG002", "value": "29"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "52.7", "spread": "12.2"}, {"groupId": "BG001", "value": "47.1", "spread": "10.5"}, {"groupId": "BG002", "value": "49.8", "spread": "11.5"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "13"}, {"groupId": "BG001", "value": "14"}, {"groupId": "BG002", "value": "27"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "2"}]}]}]}, {"title": "Ethnicity (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "1"}]}, {"title": "Not Hispanic or Latino", "measurements": [{"groupId": "BG000", "value": "13"}, {"groupId": "BG001", "value": "15"}, {"groupId": "BG002", "value": "28"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "13"}, {"groupId": "BG001", "value": "14"}, {"groupId": "BG002", "value": "27"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "2"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "14"}, {"groupId": "BG001", "value": "15"}, {"groupId": "BG002", "value": "29"}]}]}]}, {"title": "DOSE-Nonadherence (Voils Adherence)", "description": "patients' medication adherence rates based on Voils adherence questionnaire adherence questionnaire. Scored 0-4, higher is more non-adherent", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "units on a scale", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "1.6", "spread": "0.9"}, {"groupId": "BG001", "value": "1.3", "spread": "1"}, {"groupId": "BG002", "value": "1.5", "spread": "1"}]}]}]}, {"title": "Asthma Control Test", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "units on a scale", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "14", "spread": "5.5"}, {"groupId": "BG001", "value": "16.1", "spread": "4"}, {"groupId": "BG002", "value": "15.1", "spread": "4.8"}]}]}]}, {"title": "Marks Asthma Related Quality of Life", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "units on a scale", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "33.2", "spread": "17.7"}, {"groupId": "BG001", "value": "23.2", "spread": "17.2"}, {"groupId": "BG002", "value": "28", "spread": "17.9"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Number of Participants Who Reported Experiences With the ARICA Program", "description": "Assessment of participants experiences with and perceptions of the ARICA program, as assessed by in-depth semi-structured qualitative interview.", "populationDescription": "Conducted qualitative interview of ARICA Intervention participants who completed the study.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "3 months", "groups": [{"id": "OG000", "title": "Control (Group 1)", "description": "This group is considered the control group. This group will have scheduled texts and emails for the monthly surveys after the participant completes the baseline questionnaires."}, {"id": "OG001", "title": "ARICA Intervention (Group 2)", "description": "This group is considered the intervention group. Participants in this group will receive weekly texts and emails containing asthma facts and myths. They will also complete monthly surveys and participate in asthma education sessions.\n\nARICA: Personalized ARICA (AdheRence to Inhaled Corticosteroids in Asthma) intervention package."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG001", "value": "12"}]}]}]}, {"type": "SECONDARY", "title": "Change in Patient Reported Medication Adherence as Measured by the DOSE-Nonadherence (Voils) Questionnaire", "description": "patients' medication adherence rates based on Voils adherence questionnaire adherence questionnaire. Difference from baseline to follow up. Scored 0-4, higher is more non-adherent", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "score on a scale", "timeFrame": "3 months", "groups": [{"id": "OG000", "title": "Control (Group 1)", "description": "This group is considered the control group. This group will have scheduled texts and emails for the monthly surveys after the participant completes the baseline questionnaires."}, {"id": "OG001", "title": "ARICA Intervention (Group 2)", "description": "This group is considered the intervention group. Participants in this group will receive weekly texts and emails containing asthma facts and myths. They will also complete monthly surveys and participate in asthma education sessions.\n\nARICA: Personalized ARICA (AdheRence to Inhaled Corticosteroids in Asthma) intervention package."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "15"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "0.685", "lowerLimit": "-0.0385", "upperLimit": "0.7528"}, {"groupId": "OG001", "value": "0.738", "lowerLimit": "0.1928", "upperLimit": "1.28"}]}]}]}, {"type": "SECONDARY", "title": "Change in Asthma Control as Measured by the Asthma Control Test", "description": "patient reported difference from baseline to follow up. Higher score is better asthma control. Range 5-25.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "score on a scale", "timeFrame": "3 months", "groups": [{"id": "OG000", "title": "Control (Group 1)", "description": "This group is considered the control group. This group will have scheduled texts and emails for the monthly surveys after the participant completes the baseline questionnaires."}, {"id": "OG001", "title": "ARICA Intervention (Group 2)", "description": "This group is considered the intervention group. Participants in this group will receive weekly texts and emails containing asthma facts and myths. They will also complete monthly surveys and participate in asthma education sessions.\n\nARICA: Personalized ARICA (AdheRence to Inhaled Corticosteroids in Asthma) intervention package."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "14"}, {"groupId": "OG001", "value": "14"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-2.571", "lowerLimit": "-5.1902", "upperLimit": "0.0473"}, {"groupId": "OG001", "value": "-3.5", "lowerLimit": "-6.0396", "upperLimit": "-0.9604"}]}]}]}, {"type": "SECONDARY", "title": "Change in Asthma-Related Quality of Life as Measured by the Marks Asthma-Related Quality of Life Questionnaire", "description": "Patient reported. Difference from baseline to follow up. Range 0-80, higher score means greater impact of asthma on quality of life.", "populationDescription": "Participants who completed the Marks Asthma-Related Quality of Life Questionnaire.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "score on a scale", "timeFrame": "3 months", "groups": [{"id": "OG000", "title": "Control (Group 1)", "description": "This group is considered the control group. This group will have scheduled texts and emails for the monthly surveys after the participant completes the baseline questionnaires."}, {"id": "OG001", "title": "ARICA Intervention (Group 2)", "description": "This group is considered the intervention group. Participants in this group will receive weekly texts and emails containing asthma facts and myths. They will also complete monthly surveys and participate in asthma education sessions.\n\nARICA: Personalized ARICA (AdheRence to Inhaled Corticosteroids in Asthma) intervention package."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "13"}, {"groupId": "OG001", "value": "13"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "5.769", "lowerLimit": "-1.2527", "upperLimit": "12.7912"}, {"groupId": "OG001", "value": "11.462", "lowerLimit": "5.5068", "upperLimit": "17.4163"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "Study period, 3 months", "eventGroups": [{"id": "EG000", "title": "Control (Group 1)", "description": "This group is considered the control group. This group will have scheduled texts and emails for the monthly surveys after the participant completes the baseline questionnaires.", "deathsNumAffected": 0, "deathsNumAtRisk": 14, "seriousNumAffected": 0, "seriousNumAtRisk": 14, "otherNumAffected": 0, "otherNumAtRisk": 14}, {"id": "EG001", "title": "ARICA Intervention (Group 2)", "description": "This group is considered the intervention group. Participants in this group will receive weekly texts and emails containing asthma facts and myths. They will also complete monthly surveys and participate in asthma education sessions.\n\nARICA: Personalized ARICA (AdheRence to Inhaled Corticosteroids in Asthma) intervention package.", "deathsNumAffected": 1, "deathsNumAtRisk": 15, "seriousNumAffected": 0, "seriousNumAtRisk": 15, "otherNumAffected": 0, "otherNumAtRisk": 15}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": true}, "pointOfContact": {"title": "Isaretta L. Riley, MD, MPH", "organization": "Duke", "email": "isaretta.riley@duke.edu", "phone": "919-286-0411"}}}, "documentSection": {"largeDocumentModule": {"noSap": true, "largeDocs": [{"typeAbbrev": "Prot", "hasProtocol": true, "hasSap": false, "hasIcf": false, "label": "Study Protocol", "date": "2020-12-14", "uploadDate": "2021-11-18T16:19", "filename": "Prot_000.pdf", "size": 136712}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M27137", "name": "Respiratory Aspiration", "relevance": "LOW"}, {"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "BC20", "name": "Immune System Diseases"}]}}, "hasResults": true}